Citations

Showing 10 of 108162 citations.

Multidisciplinary Evaluation and Management of Cortical Deafness and Other Related Central Hearing Impairments
Dumanch, Kelsey, Poling, Gayla L.

Mayo Clinic

Perspectives of the ASHA Special Interest Groups | October 28, 2019 | Volume: 4 | Issue: 5 | Pages: 910-935

10.1044/2019_pers-sig6-2019-0002 Get It

PurposeA summary of literature surrounding cortical hearing impairment (cortical deafness, auditory agnosia, and pure word deafness) was studied to identify causes and prognoses of the disorders, in addition to assessment methods and rehabilitation strategies for the multidisciplinary care team setting.MethodA comprehensive review of the literature surrounding cortical hearing impairment with a focus on clinical evaluation and management of patients with these conditions was performed.ResultsAn extensive literature search resulted in 109 relevant articles discussing cases of cortical hearing impairment.ConclusionsCortical deafness continues to be the rarest of the cortical hearing impairment spectrum of disorders, with reports of auditory agnosia and pure word deafness appearing more commonly. In order to assess and manage patients with these conditions, audiologists must utilize a comprehensive set of clinical tools. This information must be combined with results of thorough multidisciplinary evaluations in order to better characterize diagnoses and outcomes for these patients. Continued reporting of case studies and summaries of the literature is encouraged, with a specific call for more consistent assessment and reporting formats.
Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease
Al‐Shaikh, Fadi S. Hanna , Duara, Ranjan , Lesser, Elizabeth R. , Schaeverbeke, Jolien , Hinkle, Kelly M., Ross, Owen A. , Ertekin‐Taner, Nilüfer , Pedraza, Otto , Graff‐Radford, Neill R. , Murray, Melissa E. , Hanna Al-Shaikh, Fadi S, Crook, Julia E. , Ross, Owen A , Murray, Melissa E , Duara, Ranjan , Dickson, Dennis W.

Mayo Clinic

JAMA Neurology | October 28, 2019 | Volume: 77 | Issue: 2 | Pages: 225

10.1001/jamaneurol.2019.3606 | PMID 31657834 Get It

Addressing Cardiovascular Health Disparities in Minnesota: Establishment of a Community Steering Committee by FAITH! (Fostering African-American Improvement in Total Health)
Manjunath, Chandrika , Ifelayo, Oluwatomilona I., Jones, Clarence , Washington, Monisha, Shanedling, Stanton , Williams, J. Sherwood, Brewer, LaPrincess C. , Ifelayo, Oluwatomilona , Patten, Christi A. , Brewer, LaPrincess C , Cooper, Lisa A.

Mayo Clinic

International Journal of Environmental Research and Public Health | October 28, 2019 | Volume: 16 | Issue: 21 | Pages: 4144

10.3390/ijerph16214144 | PMID 31661826 Get It

Despite its rank as the fourth healthiest state in the United States, Minnesota has clear cardiovascular disease disparities between African-Americans and whites. Culturally-tailored interventions implemented using community-based participatory research (CBPR) principles have been vital to improving health and wellness among African-Americans. This paper delineates the establishment, impact, and lessons learned from the formation of a community steering committee (CSC) to guide the Fostering African-American Improvement in Total Health (FAITH!) Program, a CBPR cardiovascular health promotion initiative among African-Americans in Minnesota. The theory-informed CSC implementation process included three phases: (1) Membership Formation and Recruitment, (2) Engagement, and (3) Covenant Development and Empowerment. The CSC is comprised of ten diverse community members guided by mutually agreed upon bylaws in their commitment to FAITH!. Overall, members considered the CSC implementation process effective and productive. A CBPR conceptual model provided an outline of proximal and distal goals for the CSC and FAITH!. The CSC implementation process yielded four lessons learned: (1) Have clarity of purpose and vision, (2) cultivate group cohesion, (3) employ consistent review of CBPR tenets, and (4) expect the unexpected. A robust CSC was established and was instrumental to the success and impact of FAITH! within African-American communities in Minnesota.
Rediscovering Renovascular Hypertension
Textor, Stephen C., Taler, Sandra J.

Mayo Clinic

Hypertension | October 28, 2019 | Volume: 74 | Issue: 6 | Pages: 1297-1299

10.1161/hypertensionaha.119.13515 | PMID 31656097 Get It

Vascular reactivity to mental stress is associated with poor cardiovascular disease outcomes in females following acute coronary syndrome
Prasad, Megha , Sara, Jaskanwal Deep Singh , Reriani, Martin, Lerman, Lilach O. , Widmer, Robert J, Sara, Jaskanwal Deep S, Reriani, Martin K, Widmer, R. Jay , Gomaa, Mohammed, Suwaidi, Jassim Al , Lerman, Amir

Mayo Clinic

Coronary Artery Disease | October 28, 2019 | Volume: 31 | Issue: 3 | Pages: 300-305

10.1097/mca.0000000000000831 | PMID 31658132 Get It

Background: We aimed to test the hypothesis that peripheral endothelial dysfunction induced by mental stress may predict cardiovascular events after acute coronary syndrome beyond traditional cardiovascular disease risk factors. Methods: This was a prospective study in which 417 patients who had acute coronary syndrome were enrolled in two sites at the US and Qatar. Cardiovascular disease risk factors such as past medical history, blood pressure, heart rate, peripheral endothelial dysfunction, and response to three different mental stress examinations (Stroop Color Word, Arithmetic, and Spiral Omnibus) as assessed by ratio of reactive hyperemia tonometry (EndoPAT) with stress over EndoPAT at rest were obtained at baseline. Major adverse cardiac events were then recorded at 1 year after the index event. Results: There were no differences in baseline peripheral endothelial dysfunction or vascular response to mental stress between the US vs. Qatar patients. Women were more likely to experience major adverse cardiac events in the year following acute coronary syndrome (relative risk 2.42, 95% confidence interval 1.53–3.84, P = 0.044), and had a significantly lower mental stress ratio compared to women who did not (1.0 ± 0.17 vs. 1.20 ± 0.17, P = 0.04). In multivariate analyses stratified by sex, baseline peripheral endothelial dysfunction (EndoPAT < 1.7) (χ2 = 8.0, P = 0.005) and mental stress ratio (χ2 = 7.7, P = 0.006), were independently predictive of major adverse cardiac events in women, but not men. Conclusion: The current study demonstrates that in women both baseline endothelial function and vascular function in response to mental stress ratio are predictive of worse cardiovascular disease outcomes 1 year after acute coronary syndrome. The study may suggest an important mechanism for adverse clinical outcomes in women following acute coronary syndrome.
Delayed Gastric Emptying Associates With Diabetic Complications in Diabetic Patients With Symptoms of Gastroparesis
Wilson, Laura , Farrugia, Gianrico , Koch, Kenneth L. , Snape, William J., Clarke, John O. , McCallum, Richard W. , Sarosiek, Irene , Grover, Madhusudan , Miriel, Laura , Tonascia, James , Hamilton, Frank A., Pasricha, Pankaj J. , Clarke, J , Parkman, Henry P. , Hasler, William L. , Nguyen, Linda Anh B. , Abell, Thomas L. , Kuo, Braden

Mayo Clinic

American Journal of Gastroenterology | October 28, 2019 | Volume: 114 | Issue: 11 | Pages: 1778-1794

10.14309/ajg.0000000000000410 | PMID 31658129 Get It

OBJECTIVES: Diabetic gastroparesis (Gp) occurs more often in type 1 diabetes mellitus (T1DM) than in type 2 diabetes mellitus (T2DM). Other diabetic end-organ complications include peripheral neuropathy, nephropathy, and retinopathy (together termed triopathy ). This study determines the prevalence of diabetic complications (retinopathy, nephropathy, and peripheral neuropathy) in diabetic patients with symptoms of Gp, assessing the differences between T1DM and T2DM and delayed and normal gastric emptying (GE). METHODS: Diabetic patients with symptoms of Gp underwent history and physical examination, GE scintigraphy, electrogastrography with water load, autonomic function testing, and questionnaires assessing symptoms and peripheral neuropathy. RESULTS: One hundred thirty-three diabetic patients with symptoms of Gp were studied: 59 with T1DM and 74 with T2DM and 103 with delayed GE and 30 without delayed GE. The presence of retinopathy (37% vs 24%; P = 0.13), nephropathy (19% vs 11%; P = 0.22), and peripheral neuropathy (53% vs 39%; P = 0.16) was not significantly higher in T1DM than in T2DM; however, triopathies (all 3 complications together) were seen in 10% of T1DM and 3% of T2DM ( P = 0.04). Diabetic patients with delayed GE had increased prevalence of retinopathy (36% vs 10%; P = 0.006) and number of diabetic complications (1.0 vs 0.5; P = 0.009); however, 39% of diabetic patients with delayed GE did not have any diabetic complications. DISCUSSION: In diabetic patients with symptoms of Gp, delayed GE was associated with the presence of retinopathy and the total number of diabetic complications. Only 10% of patients with T1DM and 3% of those with T2DM had triopathy of complications, and 39% of diabetic patients with Gp did not have any diabetic complications. Thus, the presence of diabetic complications should raise awareness for Gp in either T1DM or T2DM; however, diabetic Gp frequently occurs without other diabetic complications.
Kidney transplant practice patterns and outcome benchmarks over 30 years: The 2018 report of the NAPRTCS
Chua, Annabelle N. , Cramer, Carl H. , Martz, Karen, Smith, Jodi M. , Blydt‐Hansen, Tom , Neu, Alicia M. , Dharnidharka, Vikas R. , investigators, the NAPRTCS, Cramer, Carl, Blydt-Hansen, Tom , Dharnidharka, Vikas R , Smith, Jodi , Moudgil, Asha , investigators, the NAPRTCS

Mayo Clinic

Pediatric Transplantation | October 28, 2019 | Volume: 23 | Issue: 8 | Pages: No page available

10.1111/petr.13597 | PMID 31657095 Get It

Abstract The NAPRTCS has collected clinical information on children undergoing renal transplantation since 1987 and now includes information on 12 920 renal transplants in 11 870 patients. Since the first data analysis in 1989, NAPRTCS reports have documented marked improvements in patient and allograft outcomes after pediatric renal transplantation in addition to identifying factors associated with both favorable and poor outcomes. The registry has served to document and influence practice patterns, clinical outcomes, and changing trends in renal transplantation and also provides historical perspective. This report highlights current practices in an era of major changes in DD kidney allocation and continuing steroid minimization. This report presents outcomes of the patients in the NAPRTCS transplant registry up to end of 2017. In particular, an increase in the cumulative incidence of late first AR has occurred in the most recent cohort, while all prior cohorts had a lower cumulative incidence of late first AR.
Injectable Flexible Subcutaneous Electrode Array Technology for Electrocardiogram Monitoring Device
Bong, Jihye , Yasin, Omar , Vaidya, Vaibhav R. , Park, Jeongpil , Padmanabhan, Deepak , Cho, Sang June , Asirvatham, Roshini, Schneider, Noah, Lee, Juhwan , Kim, Eun‐Mee , Friedman, Paul A. , Cho, Sang June , Lee, Juhwan , Ma, Zhenqiang , Attia, Zachi I.

Mayo Clinic

ACS Biomaterials Science & Engineering | October 26, 2019 | Volume: 6 | Issue: 5 | Pages: 2652-2658

10.1021/acsbiomaterials.9b01102 | PMID 33463304 Get It

Challenging dogma: report of a spinal cord arteriovenous malformation as an acquired lesion in a pediatric patient
Brinjikji, Waleed , Ahn, Edward S. , Patterson, Marc C. , Lanzino, Giuseppe

Mayo Clinic

Journal of Neurosurgery: Spine | October 26, 2019 | Volume: 32 | Issue: 2 | Pages: 302-304

10.3171/2019.7.spine19253 | PMID 31653811 Get It

Spinal cord intramedullary arteriovenous malformations (AVMs) have classically been considered congenital lesions that are present from birth. The reason for this dogmatic principal is the fact that a vast majority of these lesions present in pediatric and young adult patients. Interestingly, while many authors have demonstrated the development of de novo nidus-type brain AVMs, there have been no reported cases of a de novo intramedullary or perimedullary AVM of the spine. In this paper the authors describe what they believe to be the first reported case of a de novo AVM of the spinal cord in a young patient who underwent serial imaging from birth for evaluation of a syrinx. Potential pathophysiological mechanisms for the development of de novo vascular malformations of the spinal cord are discussed.
Comparison of Biologic Discontinuation in Patients With Elderly‐Onset Versus Younger‐Onset Rheumatoid Arthritis
Richter, Michael , Matteson, Eric L. , Achenbach, Sara J., Crowson, Cynthia S. , Richter, Michael D , Crowson, CS , Davis, John M.

Mayo Clinic

ACR Open Rheumatology | October 26, 2019 | Volume: 1 | Issue: 10 | Pages: 627-631

10.1002/acr2.11083 | PMID 31872184 Get It

ObjectiveThe objective of this study is to compare biologic drug discontinuation rates for older‐ versus younger‐onset rheumatoid arthritis (YORA) because this is a key outcome measure that could impact prescribing practices.MethodsWe performed a retrospective medical record review of all patients who fulfilled the 1987 American College of Rheumatology (ACR) criteria for adult‐onset rheumatoid arthritis (RA) in 1999‐2013 among residents of a geographically defined area, with follow‐up until death, migration, or July 1, 2017. Discontinuation rates were estimated using cumulative incidence adjusted for the competing risk of death.ResultsA total of 240 cases of elderly‐onset rheumatoid arthritis (EORA) and 366 cases of YORA were identified (65% and 73% female, respectively; P = 0.025). Cumulative incidence of biologic initiation was lower among the EORA cohort compared with the YORA cohort (18% vs 33%, respectively, at 10 years after RA incidence; P < 0.001). Among those treated with a biologic, years from RA diagnosis to first biologic treatment was not significantly different between the two groups (P = 0.62). Drug survival of first biologic was 64% at 1 year (95% confidence interval [CI]: 45%‐77%) and 53% at 2 years (95% CI: 33%‐66%) for EORA, compared with 61% at 1 year (95% CI: 50%‐69%) and 45% at 2 years (95% CI: 34%‐53%) for YORA (P = 0.75). Concurrent glucocorticoid use at initiation of first biologic was statistically and significantly associated with a lower risk of discontinuation in EORA (hazard ratio 0.21; 95% CI: 0.08‐0.53) but not in YORA (interaction P = 0.04).ConclusionDrug survival rates of biologic medications did not differ significantly between patients with EORA and YORA.